Announced

6 Aug 2020

Completed

6 Aug 2020

Alembic Pharma raised $100m via QIA.

Synopsis

India investors Tata Mutual Fund, HDFC Life, Sundaram, Bajaj Life and Nippon India Mutual Fund completed a $100m investment in Alembic Pharma, an Indian multinational pharmaceutical company.

Principals

target

Alembic Pharma

bidder

Tata Mutual Fund

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

chirayu amin

Chairman and CEO at ALEMBIC PHARMA

Manager

target

Deals

£ 76 M

Total Value

Bidder Team (4)

tarun chugh

CEO at BAJAJ ALLIANZ LIFE INSURANCE

Manager

bidder

Deal

£ 76 M

Total Value

sunil subramaniam

CEO at SUNDARAM MUTUAL

Manager

bidder

Deals

£ 110 M

Total Value

sundeep sikka

CEO at NIPPON INDIA MUTUAL FUND

Investor

bidder

Deals

£ 77 M

Total Value

vibha padalkar

CEO at HDFC LIFE

Manager

bidder

Deals

£ 76 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy